nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—RRM1—lung cancer	0.299	1	CbGaD
Fludarabine—Cytarabine—Gemcitabine—lung cancer	0.0907	0.513	CrCrCtD
Fludarabine—SLC29A1—Pemetrexed—lung cancer	0.0878	0.231	CbGbCtD
Fludarabine—Azacitidine—Gemcitabine—lung cancer	0.0862	0.487	CrCrCtD
Fludarabine—DCK—Pemetrexed—lung cancer	0.0814	0.214	CbGbCtD
Fludarabine—RRM1—Gemcitabine—lung cancer	0.055	0.145	CbGbCtD
Fludarabine—SLC28A3—Gemcitabine—lung cancer	0.0476	0.125	CbGbCtD
Fludarabine—POLA1—Gemcitabine—lung cancer	0.0476	0.125	CbGbCtD
Fludarabine—SLC29A1—Gemcitabine—lung cancer	0.0316	0.0831	CbGbCtD
Fludarabine—DCK—Gemcitabine—lung cancer	0.0293	0.077	CbGbCtD
Fludarabine—POLA1—mammary gland—lung cancer	0.0018	0.0846	CbGeAlD
Fludarabine—SLC28A3—respiratory system—lung cancer	0.00171	0.0802	CbGeAlD
Fludarabine—RRM1—mammary gland—lung cancer	0.00143	0.0671	CbGeAlD
Fludarabine—SLC28A3—trachea—lung cancer	0.00126	0.0593	CbGeAlD
Fludarabine—SLC29A1—mammary gland—lung cancer	0.00116	0.0546	CbGeAlD
Fludarabine—SLC28A3—bone marrow—lung cancer	0.001	0.047	CbGeAlD
Fludarabine—RRM1—respiratory system—lung cancer	0.000951	0.0447	CbGeAlD
Fludarabine—SLC28A3—lung—lung cancer	0.000906	0.0426	CbGeAlD
Fludarabine—RRM1—bronchus—lung cancer	0.000783	0.0368	CbGeAlD
Fludarabine—SLC29A1—respiratory system—lung cancer	0.000774	0.0364	CbGeAlD
Fludarabine—POLA1—bone marrow—lung cancer	0.000703	0.033	CbGeAlD
Fludarabine—RRM1—cardiac atrium—lung cancer	0.000661	0.0311	CbGeAlD
Fludarabine—SLC29A1—bronchus—lung cancer	0.000637	0.0299	CbGeAlD
Fludarabine—POLA1—lung—lung cancer	0.000637	0.0299	CbGeAlD
Fludarabine—DCK—bronchus—lung cancer	0.000608	0.0286	CbGeAlD
Fludarabine—SLC29A1—trachea—lung cancer	0.000572	0.0269	CbGeAlD
Fludarabine—DCK—Topotecan—Irinotecan—lung cancer	0.000564	0.375	CbGdCrCtD
Fludarabine—RRM1—bone marrow—lung cancer	0.000558	0.0262	CbGeAlD
Fludarabine—DCK—trachea—lung cancer	0.000546	0.0257	CbGeAlD
Fludarabine—SLC29A1—cardiac atrium—lung cancer	0.000537	0.0253	CbGeAlD
Fludarabine—Adenosine monophosphate—ADCY1—lung cancer	0.000532	0.212	CrCbGaD
Fludarabine—POLA1—Vinblastine—Vinorelbine—lung cancer	0.00053	0.353	CbGdCrCtD
Fludarabine—DCK—cardiac atrium—lung cancer	0.000513	0.0241	CbGeAlD
Fludarabine—RRM1—lung—lung cancer	0.000505	0.0238	CbGeAlD
Fludarabine—Adenosine triphosphate—ADCY1—lung cancer	0.000461	0.184	CrCbGaD
Fludarabine—SLC29A1—bone marrow—lung cancer	0.000453	0.0213	CbGeAlD
Fludarabine—POLA1—lymph node—lung cancer	0.000435	0.0205	CbGeAlD
Fludarabine—DCK—bone marrow—lung cancer	0.000433	0.0204	CbGeAlD
Fludarabine—Clofarabine—RRM1—lung cancer	0.000422	0.168	CrCbGaD
Fludarabine—SLC29A1—lung—lung cancer	0.000411	0.0193	CbGeAlD
Fludarabine—DCK—lung—lung cancer	0.000392	0.0185	CbGeAlD
Fludarabine—RRM1—lymph node—lung cancer	0.000346	0.0162	CbGeAlD
Fludarabine—RRM1—Azacitidine—Gemcitabine—lung cancer	0.000287	0.191	CbGdCrCtD
Fludarabine—SLC29A1—lymph node—lung cancer	0.000281	0.0132	CbGeAlD
Fludarabine—DCK—lymph node—lung cancer	0.000268	0.0126	CbGeAlD
Fludarabine—Cladribine—RRM1—lung cancer	0.000242	0.0965	CrCbGaD
Fludarabine—Flavin adenine dinucleotide—NQO1—lung cancer	0.000184	0.0732	CrCbGaD
Fludarabine—Adenosine triphosphate—ALK—lung cancer	0.00016	0.0639	CrCbGaD
Fludarabine—Adenosine triphosphate—AKT1—lung cancer	0.000125	0.0499	CrCbGaD
Fludarabine—Adenosine monophosphate—SRC—lung cancer	0.000123	0.0492	CrCbGaD
Fludarabine—DCK—Epirubicin—Doxorubicin—lung cancer	0.000123	0.0815	CbGdCrCtD
Fludarabine—Clofarabine—ABCG2—lung cancer	0.000108	0.0429	CrCbGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCG2—lung cancer	7.14e-05	0.00221	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ATP5H—lung cancer	6.85e-05	0.00212	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APP—lung cancer	6.84e-05	0.00212	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—lung cancer	6.81e-05	0.0021	CbGpPWpGaD
Fludarabine—S-Adenosylmethionine—CYP2E1—lung cancer	6.75e-05	0.0269	CrCbGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—AVP—lung cancer	6.75e-05	0.00209	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—TYMS—lung cancer	6.68e-05	0.00207	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—TF—lung cancer	6.64e-05	0.00205	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	6.59e-05	0.00204	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	6.53e-05	0.00202	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCC3—lung cancer	6.53e-05	0.00202	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	6.52e-05	0.00202	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—lung cancer	6.51e-05	0.00201	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	6.48e-05	0.002	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—lung cancer	6.44e-05	0.00199	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	6.32e-05	0.00195	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AZIN2—lung cancer	6.2e-05	0.00192	CbGpPWpGaD
Fludarabine—DCK—Metabolism—COL4A3BP—lung cancer	6.2e-05	0.00192	CbGpPWpGaD
Fludarabine—Cladribine—ABCG2—lung cancer	6.18e-05	0.0246	CrCbGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	6.14e-05	0.0019	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	6.11e-05	0.00189	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLBD1—lung cancer	6.1e-05	0.00189	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—RB1—lung cancer	5.95e-05	0.00184	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—GNG11—lung cancer	5.92e-05	0.00183	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	5.88e-05	0.00182	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	5.83e-05	0.0018	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—lung cancer	5.59e-05	0.00173	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD17B10—lung cancer	5.58e-05	0.00173	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—RB1—lung cancer	5.58e-05	0.00173	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	5.49e-05	0.0017	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—ALB—lung cancer	5.48e-05	0.0017	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	5.47e-05	0.00169	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—RB1—lung cancer	5.37e-05	0.00166	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ADCY1—lung cancer	5.32e-05	0.00165	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCG2—lung cancer	5.32e-05	0.00165	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN1A—lung cancer	5.32e-05	0.00165	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ATP5H—lung cancer	5.27e-05	0.00163	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—lung cancer	5.24e-05	0.00162	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PPP2R1B—lung cancer	5.21e-05	0.00161	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	5.19e-05	0.00161	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CKB—lung cancer	5.19e-05	0.0016	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	5.17e-05	0.0016	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	5.15e-05	0.00159	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	5.12e-05	0.00158	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—EP300—lung cancer	5.06e-05	0.00157	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	5.06e-05	0.00156	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	5.01e-05	0.00155	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—LMNA—lung cancer	4.97e-05	0.00154	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—TF—lung cancer	4.95e-05	0.00153	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM2—lung cancer	4.88e-05	0.00151	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CNDP2—lung cancer	4.88e-05	0.00151	CbGpPWpGaD
Fludarabine—POLA1—S Phase—RB1—lung cancer	4.88e-05	0.00151	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	4.78e-05	0.00148	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTMR3—lung cancer	4.75e-05	0.00147	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—FOXM1—lung cancer	4.7e-05	0.00145	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLBD1—lung cancer	4.7e-05	0.00145	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	4.65e-05	0.00144	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.65e-05	0.00144	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PGAM1—lung cancer	4.62e-05	0.00143	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	4.62e-05	0.00143	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—AVP—lung cancer	4.6e-05	0.00142	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RB1—lung cancer	4.53e-05	0.0014	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.52e-05	0.0014	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.51e-05	0.0014	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—lung cancer	4.46e-05	0.00138	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP2A7—lung cancer	4.41e-05	0.00136	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—MYC—lung cancer	4.41e-05	0.00136	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.38e-05	0.00135	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.37e-05	0.00135	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SDC4—lung cancer	4.32e-05	0.00134	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—lung cancer	4.3e-05	0.00133	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD17B10—lung cancer	4.29e-05	0.00133	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	4.28e-05	0.00132	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1A—lung cancer	4.27e-05	0.00132	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—FOXM1—lung cancer	4.2e-05	0.0013	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.16e-05	0.00129	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—lung cancer	4.09e-05	0.00126	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4.05e-05	0.00125	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDKN1A—lung cancer	4.01e-05	0.00124	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CKB—lung cancer	3.99e-05	0.00123	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—lung cancer	3.98e-05	0.00123	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.94e-05	0.00122	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA3—lung cancer	3.93e-05	0.00122	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PPP2R1B—lung cancer	3.89e-05	0.0012	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDKN1A—lung cancer	3.86e-05	0.00119	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—lung cancer	3.83e-05	0.00119	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CNDP2—lung cancer	3.75e-05	0.00116	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM2—lung cancer	3.75e-05	0.00116	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.73e-05	0.00115	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—LMNA—lung cancer	3.72e-05	0.00115	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	3.71e-05	0.00115	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—B4GALT5—lung cancer	3.7e-05	0.00114	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	3.67e-05	0.00114	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTMR3—lung cancer	3.65e-05	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.63e-05	0.00112	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCND1—lung cancer	3.62e-05	0.00112	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA4—lung cancer	3.6e-05	0.00111	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PGAM1—lung cancer	3.56e-05	0.0011	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.55e-05	0.0011	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—APOA1—lung cancer	3.52e-05	0.00109	CbGpPWpGaD
Fludarabine—Confusional state—Etoposide—lung cancer	3.51e-05	0.000407	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTA2—lung cancer	3.5e-05	0.00108	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1A—lung cancer	3.5e-05	0.00108	CbGpPWpGaD
Fludarabine—Pain—Gemcitabine—lung cancer	3.49e-05	0.000404	CcSEcCtD
Fludarabine—Constipation—Gemcitabine—lung cancer	3.49e-05	0.000404	CcSEcCtD
Fludarabine—Nausea—Erlotinib—lung cancer	3.49e-05	0.000404	CcSEcCtD
Fludarabine—Pancytopenia—Methotrexate—lung cancer	3.48e-05	0.000404	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—PPP2R1B—lung cancer	3.48e-05	0.00108	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Etoposide—lung cancer	3.48e-05	0.000404	CcSEcCtD
Fludarabine—Diarrhoea—Vinorelbine—lung cancer	3.47e-05	0.000403	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Cisplatin—lung cancer	3.46e-05	0.000401	CcSEcCtD
Fludarabine—Infection—Etoposide—lung cancer	3.46e-05	0.000401	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	3.46e-05	0.00107	CbGpPWpGaD
Fludarabine—Feeling abnormal—Irinotecan—lung cancer	3.45e-05	0.0004	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	3.44e-05	0.00106	CbGpPWpGaD
Fludarabine—Confusional state—Paclitaxel—lung cancer	3.44e-05	0.000399	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—AVP—lung cancer	3.43e-05	0.00106	CbGpPWpGaD
Fludarabine—Neutropenia—Methotrexate—lung cancer	3.43e-05	0.000398	CcSEcCtD
Fludarabine—Dysuria—Methotrexate—lung cancer	3.43e-05	0.000398	CcSEcCtD
Fludarabine—Dehydration—Doxorubicin—lung cancer	3.42e-05	0.000396	CcSEcCtD
Fludarabine—Anaphylactic shock—Paclitaxel—lung cancer	3.41e-05	0.000396	CcSEcCtD
Fludarabine—Oedema—Paclitaxel—lung cancer	3.41e-05	0.000396	CcSEcCtD
Fludarabine—Paraesthesia—Cisplatin—lung cancer	3.41e-05	0.000396	CcSEcCtD
Fludarabine—Thrombocytopenia—Etoposide—lung cancer	3.41e-05	0.000395	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Methotrexate—lung cancer	3.41e-05	0.000395	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP2A7—lung cancer	3.4e-05	0.00105	CbGpPWpGaD
Fludarabine—Liver function test abnormal—Doxorubicin—lung cancer	3.39e-05	0.000393	CcSEcCtD
Fludarabine—Infection—Paclitaxel—lung cancer	3.39e-05	0.000393	CcSEcCtD
Fludarabine—Dyspnoea—Cisplatin—lung cancer	3.39e-05	0.000393	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTA1—lung cancer	3.38e-05	0.00105	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Etoposide—lung cancer	3.37e-05	0.00039	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—lung cancer	3.36e-05	0.00104	CbGpPWpGaD
Fludarabine—Feeling abnormal—Gemcitabine—lung cancer	3.36e-05	0.00039	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.35e-05	0.00104	CbGpPWpGaD
Fludarabine—Nervous system disorder—Paclitaxel—lung cancer	3.35e-05	0.000388	CcSEcCtD
Fludarabine—RRM1—Metabolism—ABCC3—lung cancer	3.34e-05	0.00103	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Paclitaxel—lung cancer	3.34e-05	0.000387	CcSEcCtD
Fludarabine—DCK—Metabolism—SDC4—lung cancer	3.32e-05	0.00103	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—LMNA—lung cancer	3.32e-05	0.00103	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—lung cancer	3.32e-05	0.00103	CbGpPWpGaD
Fludarabine—Anorexia—Etoposide—lung cancer	3.32e-05	0.000385	CcSEcCtD
Fludarabine—Body temperature increased—Irinotecan—lung cancer	3.31e-05	0.000384	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	3.31e-05	0.000384	CcSEcCtD
Fludarabine—Decreased appetite—Cisplatin—lung cancer	3.3e-05	0.000383	CcSEcCtD
Fludarabine—Hyperhidrosis—Paclitaxel—lung cancer	3.3e-05	0.000383	CcSEcCtD
Fludarabine—Pneumonia—Methotrexate—lung cancer	3.29e-05	0.000381	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	3.29e-05	0.00102	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Cisplatin—lung cancer	3.28e-05	0.00038	CcSEcCtD
Fludarabine—Anaemia—Docetaxel—lung cancer	3.28e-05	0.00038	CcSEcCtD
Fludarabine—Anorexia—Paclitaxel—lung cancer	3.25e-05	0.000377	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—lung cancer	3.25e-05	0.00101	CbGpPWpGaD
Fludarabine—Pain—Cisplatin—lung cancer	3.25e-05	0.000377	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Methotrexate—lung cancer	3.24e-05	0.000376	CcSEcCtD
Fludarabine—RRM1—Metabolism—AKR1C1—lung cancer	3.24e-05	0.001	CbGpPWpGaD
Fludarabine—Vomiting—Vinorelbine—lung cancer	3.23e-05	0.000374	CcSEcCtD
Fludarabine—Body temperature increased—Gemcitabine—lung cancer	3.22e-05	0.000374	CcSEcCtD
Fludarabine—Renal failure—Methotrexate—lung cancer	3.21e-05	0.000373	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—MYC—lung cancer	3.2e-05	0.00099	CbGpPWpGaD
Fludarabine—Rash—Vinorelbine—lung cancer	3.2e-05	0.000371	CcSEcCtD
Fludarabine—Dermatitis—Vinorelbine—lung cancer	3.2e-05	0.000371	CcSEcCtD
Fludarabine—Stomatitis—Methotrexate—lung cancer	3.19e-05	0.000369	CcSEcCtD
Fludarabine—Headache—Vinorelbine—lung cancer	3.18e-05	0.000369	CcSEcCtD
Fludarabine—Dysphagia—Doxorubicin—lung cancer	3.18e-05	0.000368	CcSEcCtD
Fludarabine—Leukopenia—Docetaxel—lung cancer	3.17e-05	0.000368	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—lung cancer	3.15e-05	0.000973	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UGT1A1—lung cancer	3.14e-05	0.000972	CbGpPWpGaD
Fludarabine—Feeling abnormal—Cisplatin—lung cancer	3.13e-05	0.000363	CcSEcCtD
Fludarabine—Paraesthesia—Etoposide—lung cancer	3.13e-05	0.000362	CcSEcCtD
Fludarabine—Haematuria—Methotrexate—lung cancer	3.12e-05	0.000361	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Paclitaxel—lung cancer	3.11e-05	0.000361	CcSEcCtD
Fludarabine—Dyspnoea—Etoposide—lung cancer	3.1e-05	0.00036	CcSEcCtD
Fludarabine—Cough—Docetaxel—lung cancer	3.09e-05	0.000359	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—lung cancer	3.09e-05	0.000359	CcSEcCtD
Fludarabine—Epistaxis—Methotrexate—lung cancer	3.08e-05	0.000358	CcSEcCtD
Fludarabine—Hypersensitivity—Irinotecan—lung cancer	3.08e-05	0.000357	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.08e-05	0.000952	CbGpPWpGaD
Fludarabine—Convulsion—Docetaxel—lung cancer	3.07e-05	0.000356	CcSEcCtD
Fludarabine—Paraesthesia—Paclitaxel—lung cancer	3.07e-05	0.000355	CcSEcCtD
Fludarabine—Bronchitis—Doxorubicin—lung cancer	3.05e-05	0.000354	CcSEcCtD
Fludarabine—Dyspnoea—Paclitaxel—lung cancer	3.04e-05	0.000353	CcSEcCtD
Fludarabine—RRM1—Metabolism—GNG11—lung cancer	3.03e-05	0.000937	CbGpPWpGaD
Fludarabine—Decreased appetite—Etoposide—lung cancer	3.03e-05	0.000351	CcSEcCtD
Fludarabine—DCK—Metabolism—RRM1—lung cancer	3.03e-05	0.000936	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA3—lung cancer	3.03e-05	0.000936	CbGpPWpGaD
Fludarabine—Arthralgia—Docetaxel—lung cancer	3.02e-05	0.00035	CcSEcCtD
Fludarabine—Myalgia—Docetaxel—lung cancer	3.02e-05	0.00035	CcSEcCtD
Fludarabine—Pancytopenia—Doxorubicin—lung cancer	3.02e-05	0.00035	CcSEcCtD
Fludarabine—Nausea—Vinorelbine—lung cancer	3.01e-05	0.000349	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Etoposide—lung cancer	3.01e-05	0.000348	CcSEcCtD
Fludarabine—Dyspepsia—Paclitaxel—lung cancer	3.01e-05	0.000348	CcSEcCtD
Fludarabine—Body temperature increased—Cisplatin—lung cancer	3e-05	0.000348	CcSEcCtD
Fludarabine—Asthenia—Irinotecan—lung cancer	3e-05	0.000348	CcSEcCtD
Fludarabine—Fatigue—Etoposide—lung cancer	3e-05	0.000348	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.98e-05	0.000921	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—CREBBP—lung cancer	2.98e-05	0.000921	CbGpPWpGaD
Fludarabine—Constipation—Etoposide—lung cancer	2.98e-05	0.000345	CcSEcCtD
Fludarabine—Pain—Etoposide—lung cancer	2.98e-05	0.000345	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—lung cancer	2.97e-05	0.000344	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—lung cancer	2.97e-05	0.000344	CcSEcCtD
Fludarabine—Decreased appetite—Paclitaxel—lung cancer	2.97e-05	0.000344	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Doxorubicin—lung cancer	2.95e-05	0.000342	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—lung cancer	2.95e-05	0.000342	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Paclitaxel—lung cancer	2.95e-05	0.000342	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—lung cancer	2.95e-05	0.000911	CbGpPWpGaD
Fludarabine—Fatigue—Paclitaxel—lung cancer	2.94e-05	0.000341	CcSEcCtD
Fludarabine—Haemorrhage—Methotrexate—lung cancer	2.94e-05	0.00034	CcSEcCtD
Fludarabine—Asthenia—Gemcitabine—lung cancer	2.93e-05	0.000339	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.92e-05	0.000904	CbGpPWpGaD
Fludarabine—Constipation—Paclitaxel—lung cancer	2.92e-05	0.000338	CcSEcCtD
Fludarabine—Pain—Paclitaxel—lung cancer	2.92e-05	0.000338	CcSEcCtD
Fludarabine—Confusional state—Docetaxel—lung cancer	2.92e-05	0.000338	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.91e-05	0.000901	CbGpPWpGaD
Fludarabine—Pharyngitis—Methotrexate—lung cancer	2.91e-05	0.000338	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—lung cancer	2.91e-05	0.000899	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Docetaxel—lung cancer	2.89e-05	0.000335	CcSEcCtD
Fludarabine—Oedema—Docetaxel—lung cancer	2.89e-05	0.000335	CcSEcCtD
Fludarabine—RRM1—Metabolism—ALDOA—lung cancer	2.89e-05	0.000892	CbGpPWpGaD
Fludarabine—Pruritus—Gemcitabine—lung cancer	2.88e-05	0.000334	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.88e-05	0.000892	CbGpPWpGaD
Fludarabine—Infection—Docetaxel—lung cancer	2.87e-05	0.000333	CcSEcCtD
Fludarabine—Feeling abnormal—Etoposide—lung cancer	2.87e-05	0.000333	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—lung cancer	2.86e-05	0.000332	CcSEcCtD
Fludarabine—Diarrhoea—Irinotecan—lung cancer	2.86e-05	0.000332	CcSEcCtD
Fludarabine—Pneumonia—Doxorubicin—lung cancer	2.85e-05	0.00033	CcSEcCtD
Fludarabine—DCK—Metabolism—B4GALT5—lung cancer	2.85e-05	0.00088	CbGpPWpGaD
Fludarabine—Nervous system disorder—Docetaxel—lung cancer	2.84e-05	0.000329	CcSEcCtD
Fludarabine—Thrombocytopenia—Docetaxel—lung cancer	2.83e-05	0.000328	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—lung cancer	2.83e-05	0.000328	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.82e-05	0.000872	CbGpPWpGaD
Fludarabine—Feeling abnormal—Paclitaxel—lung cancer	2.81e-05	0.000326	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	2.81e-05	0.000325	CcSEcCtD
Fludarabine—RRM1—Metabolism—NCOA3—lung cancer	2.8e-05	0.000866	CbGpPWpGaD
Fludarabine—Hypersensitivity—Cisplatin—lung cancer	2.8e-05	0.000325	CcSEcCtD
Fludarabine—Diarrhoea—Gemcitabine—lung cancer	2.79e-05	0.000323	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—lung cancer	2.79e-05	0.000862	CbGpPWpGaD
Fludarabine—Renal failure—Doxorubicin—lung cancer	2.78e-05	0.000323	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—lung cancer	2.78e-05	0.000322	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—lung cancer	2.78e-05	0.000322	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTA4—lung cancer	2.77e-05	0.000856	CbGpPWpGaD
Fludarabine—Stomatitis—Doxorubicin—lung cancer	2.76e-05	0.00032	CcSEcCtD
Fludarabine—Anorexia—Docetaxel—lung cancer	2.76e-05	0.00032	CcSEcCtD
Fludarabine—Body temperature increased—Etoposide—lung cancer	2.75e-05	0.000319	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—lung cancer	2.75e-05	0.000319	CcSEcCtD
Fludarabine—Asthenia—Cisplatin—lung cancer	2.73e-05	0.000316	CcSEcCtD
Fludarabine—RRM1—Metabolism—ADCY1—lung cancer	2.73e-05	0.000843	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCG2—lung cancer	2.73e-05	0.000843	CbGpPWpGaD
Fludarabine—Haematuria—Doxorubicin—lung cancer	2.7e-05	0.000313	CcSEcCtD
Fludarabine—Body temperature increased—Paclitaxel—lung cancer	2.7e-05	0.000313	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—lung cancer	2.7e-05	0.000834	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA2—lung cancer	2.7e-05	0.000834	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ENO2—lung cancer	2.67e-05	0.000827	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HPGDS—lung cancer	2.67e-05	0.000827	CbGpPWpGaD
Fludarabine—Epistaxis—Doxorubicin—lung cancer	2.67e-05	0.00031	CcSEcCtD
Fludarabine—Vomiting—Irinotecan—lung cancer	2.66e-05	0.000309	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—lung cancer	2.66e-05	0.000308	CcSEcCtD
Fludarabine—RRM1—Metabolism—PPP2R1B—lung cancer	2.66e-05	0.000821	CbGpPWpGaD
Fludarabine—Rash—Irinotecan—lung cancer	2.64e-05	0.000306	CcSEcCtD
Fludarabine—Dermatitis—Irinotecan—lung cancer	2.64e-05	0.000306	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Docetaxel—lung cancer	2.64e-05	0.000306	CcSEcCtD
Fludarabine—Chills—Methotrexate—lung cancer	2.63e-05	0.000305	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—APOA1—lung cancer	2.62e-05	0.000811	CbGpPWpGaD
Fludarabine—Headache—Irinotecan—lung cancer	2.62e-05	0.000304	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.62e-05	0.000809	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA1—lung cancer	2.6e-05	0.000805	CbGpPWpGaD
Fludarabine—Diarrhoea—Cisplatin—lung cancer	2.6e-05	0.000301	CcSEcCtD
Fludarabine—Paraesthesia—Docetaxel—lung cancer	2.6e-05	0.000301	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—lung cancer	2.59e-05	0.000301	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTT1—lung cancer	2.59e-05	0.000802	CbGpPWpGaD
Fludarabine—Vomiting—Gemcitabine—lung cancer	2.59e-05	0.000301	CcSEcCtD
Fludarabine—Dyspnoea—Docetaxel—lung cancer	2.58e-05	0.000299	CcSEcCtD
Fludarabine—DCK—Metabolism—ABCC3—lung cancer	2.57e-05	0.000796	CbGpPWpGaD
Fludarabine—Rash—Gemcitabine—lung cancer	2.57e-05	0.000298	CcSEcCtD
Fludarabine—Dermatitis—Gemcitabine—lung cancer	2.57e-05	0.000298	CcSEcCtD
Fludarabine—Hypersensitivity—Etoposide—lung cancer	2.57e-05	0.000297	CcSEcCtD
Fludarabine—RRM1—Metabolism—GCLC—lung cancer	2.56e-05	0.000792	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP2A6—lung cancer	2.56e-05	0.000792	CbGpPWpGaD
Fludarabine—Malnutrition—Methotrexate—lung cancer	2.56e-05	0.000296	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—lung cancer	2.55e-05	0.000296	CcSEcCtD
Fludarabine—Headache—Gemcitabine—lung cancer	2.55e-05	0.000296	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	2.55e-05	0.000788	CbGpPWpGaD
Fludarabine—Dyspepsia—Docetaxel—lung cancer	2.55e-05	0.000295	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	2.54e-05	0.000786	CbGpPWpGaD
Fludarabine—Haemorrhage—Doxorubicin—lung cancer	2.54e-05	0.000295	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—lung cancer	2.53e-05	0.000293	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—lung cancer	2.52e-05	0.000292	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—RAF1—lung cancer	2.52e-05	0.000779	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.52e-05	0.000778	CbGpPWpGaD
Fludarabine—Decreased appetite—Docetaxel—lung cancer	2.52e-05	0.000292	CcSEcCtD
Fludarabine—Hypersensitivity—Paclitaxel—lung cancer	2.52e-05	0.000292	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Docetaxel—lung cancer	2.5e-05	0.00029	CcSEcCtD
Fludarabine—Asthenia—Etoposide—lung cancer	2.5e-05	0.00029	CcSEcCtD
Fludarabine—Fatigue—Docetaxel—lung cancer	2.49e-05	0.000289	CcSEcCtD
Fludarabine—DCK—Metabolism—AKR1C1—lung cancer	2.49e-05	0.000771	CbGpPWpGaD
Fludarabine—Nausea—Irinotecan—lung cancer	2.49e-05	0.000288	CcSEcCtD
Fludarabine—Pain—Docetaxel—lung cancer	2.47e-05	0.000287	CcSEcCtD
Fludarabine—Constipation—Docetaxel—lung cancer	2.47e-05	0.000287	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	2.46e-05	0.000762	CbGpPWpGaD
Fludarabine—Pruritus—Etoposide—lung cancer	2.46e-05	0.000286	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	2.46e-05	0.00076	CbGpPWpGaD
Fludarabine—Visual impairment—Doxorubicin—lung cancer	2.45e-05	0.000284	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—TYMS—lung cancer	2.45e-05	0.000757	CbGpPWpGaD
Fludarabine—Asthenia—Paclitaxel—lung cancer	2.45e-05	0.000284	CcSEcCtD
Fludarabine—RRM1—Metabolism—ENO1—lung cancer	2.43e-05	0.000751	CbGpPWpGaD
Fludarabine—Nausea—Gemcitabine—lung cancer	2.42e-05	0.000281	CcSEcCtD
Fludarabine—DCK—Metabolism—UGT1A1—lung cancer	2.42e-05	0.000748	CbGpPWpGaD
Fludarabine—Vomiting—Cisplatin—lung cancer	2.42e-05	0.00028	CcSEcCtD
Fludarabine—Pruritus—Paclitaxel—lung cancer	2.42e-05	0.00028	CcSEcCtD
Fludarabine—Erythema multiforme—Doxorubicin—lung cancer	2.4e-05	0.000279	CcSEcCtD
Fludarabine—Rash—Cisplatin—lung cancer	2.4e-05	0.000278	CcSEcCtD
Fludarabine—Dermatitis—Cisplatin—lung cancer	2.39e-05	0.000278	CcSEcCtD
Fludarabine—Feeling abnormal—Docetaxel—lung cancer	2.38e-05	0.000276	CcSEcCtD
Fludarabine—Diarrhoea—Etoposide—lung cancer	2.38e-05	0.000276	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—lung cancer	2.37e-05	0.000275	CcSEcCtD
Fludarabine—Anaemia—Methotrexate—lung cancer	2.36e-05	0.000274	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	2.35e-05	0.000725	CbGpPWpGaD
Fludarabine—Diarrhoea—Paclitaxel—lung cancer	2.34e-05	0.000271	CcSEcCtD
Fludarabine—DCK—Metabolism—GNG11—lung cancer	2.33e-05	0.000721	CbGpPWpGaD
Fludarabine—Malaise—Methotrexate—lung cancer	2.3e-05	0.000267	CcSEcCtD
Fludarabine—Body temperature increased—Docetaxel—lung cancer	2.29e-05	0.000265	CcSEcCtD
Fludarabine—Leukopenia—Methotrexate—lung cancer	2.29e-05	0.000265	CcSEcCtD
Fludarabine—Chills—Doxorubicin—lung cancer	2.28e-05	0.000264	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	2.28e-05	0.000705	CbGpPWpGaD
Fludarabine—Arrhythmia—Doxorubicin—lung cancer	2.27e-05	0.000263	CcSEcCtD
Fludarabine—Nausea—Cisplatin—lung cancer	2.26e-05	0.000262	CcSEcCtD
Fludarabine—Alopecia—Doxorubicin—lung cancer	2.25e-05	0.00026	CcSEcCtD
Fludarabine—Cough—Methotrexate—lung cancer	2.23e-05	0.000258	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	2.22e-05	0.000687	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALDOA—lung cancer	2.22e-05	0.000687	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—RB1—lung cancer	2.22e-05	0.000687	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.22e-05	0.000686	CbGpPWpGaD
Fludarabine—Convulsion—Methotrexate—lung cancer	2.21e-05	0.000257	CcSEcCtD
Fludarabine—Vomiting—Etoposide—lung cancer	2.21e-05	0.000257	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—lung cancer	2.21e-05	0.000256	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—BIRC5—lung cancer	2.2e-05	0.000681	CbGpPWpGaD
Fludarabine—Rash—Etoposide—lung cancer	2.2e-05	0.000254	CcSEcCtD
Fludarabine—Dermatitis—Etoposide—lung cancer	2.19e-05	0.000254	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TYMS—lung cancer	2.19e-05	0.000677	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—ABCB1—lung cancer	2.19e-05	0.00872	CrCbGaD
Fludarabine—Headache—Etoposide—lung cancer	2.18e-05	0.000253	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP2E1—lung cancer	2.18e-05	0.000674	CbGpPWpGaD
Fludarabine—Arthralgia—Methotrexate—lung cancer	2.18e-05	0.000252	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—lung cancer	2.18e-05	0.000252	CcSEcCtD
Fludarabine—Vomiting—Paclitaxel—lung cancer	2.17e-05	0.000252	CcSEcCtD
Fludarabine—DCK—Metabolism—NCOA3—lung cancer	2.16e-05	0.000667	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NQO1—lung cancer	2.15e-05	0.000666	CbGpPWpGaD
Fludarabine—Rash—Paclitaxel—lung cancer	2.15e-05	0.00025	CcSEcCtD
Fludarabine—Dermatitis—Paclitaxel—lung cancer	2.15e-05	0.000249	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—lung cancer	2.15e-05	0.000249	CcSEcCtD
Fludarabine—Headache—Paclitaxel—lung cancer	2.14e-05	0.000248	CcSEcCtD
Fludarabine—Hypersensitivity—Docetaxel—lung cancer	2.13e-05	0.000247	CcSEcCtD
Fludarabine—Confusional state—Methotrexate—lung cancer	2.1e-05	0.000244	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	2.1e-05	0.00065	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCG2—lung cancer	2.1e-05	0.000649	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ADCY1—lung cancer	2.1e-05	0.000649	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Methotrexate—lung cancer	2.09e-05	0.000242	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—lung cancer	2.08e-05	0.000643	CbGpPWpGaD
Fludarabine—Asthenia—Docetaxel—lung cancer	2.08e-05	0.000241	CcSEcCtD
Fludarabine—Infection—Methotrexate—lung cancer	2.07e-05	0.00024	CcSEcCtD
Fludarabine—Nausea—Etoposide—lung cancer	2.07e-05	0.00024	CcSEcCtD
Fludarabine—DCK—Metabolism—ENO2—lung cancer	2.06e-05	0.000636	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HPGDS—lung cancer	2.06e-05	0.000636	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Doxorubicin—lung cancer	2.05e-05	0.000238	CcSEcCtD
Fludarabine—Pruritus—Docetaxel—lung cancer	2.05e-05	0.000237	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—lung cancer	2.05e-05	0.000237	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—lung cancer	2.05e-05	0.000237	CcSEcCtD
Fludarabine—DCK—Metabolism—PPP2R1B—lung cancer	2.04e-05	0.000632	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	2.04e-05	0.000632	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Methotrexate—lung cancer	2.04e-05	0.000237	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—lung cancer	2.03e-05	0.000236	CcSEcCtD
Fludarabine—Nausea—Paclitaxel—lung cancer	2.03e-05	0.000235	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—lung cancer	2.02e-05	0.000234	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	2e-05	0.000618	CbGpPWpGaD
Fludarabine—Malaise—Doxorubicin—lung cancer	2e-05	0.000231	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTT1—lung cancer	2e-05	0.000617	CbGpPWpGaD
Fludarabine—Anorexia—Methotrexate—lung cancer	1.99e-05	0.00023	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—lung cancer	1.98e-05	0.00023	CcSEcCtD
Fludarabine—Diarrhoea—Docetaxel—lung cancer	1.98e-05	0.00023	CcSEcCtD
Fludarabine—DCK—Metabolism—GCLC—lung cancer	1.97e-05	0.00061	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP2A6—lung cancer	1.97e-05	0.00061	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—BIRC5—lung cancer	1.97e-05	0.000609	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—STK11—lung cancer	1.94e-05	0.000601	CbGpPWpGaD
Fludarabine—Cough—Doxorubicin—lung cancer	1.93e-05	0.000224	CcSEcCtD
Fludarabine—Convulsion—Doxorubicin—lung cancer	1.92e-05	0.000222	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TERT—lung cancer	1.91e-05	0.00059	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Methotrexate—lung cancer	1.9e-05	0.00022	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.89e-05	0.000584	CbGpPWpGaD
Fludarabine—Arthralgia—Doxorubicin—lung cancer	1.88e-05	0.000218	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—lung cancer	1.88e-05	0.000218	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—RAF1—lung cancer	1.88e-05	0.000581	CbGpPWpGaD
Fludarabine—Paraesthesia—Methotrexate—lung cancer	1.87e-05	0.000217	CcSEcCtD
Fludarabine—DCK—Metabolism—ENO1—lung cancer	1.87e-05	0.000578	CbGpPWpGaD
Fludarabine—Discomfort—Doxorubicin—lung cancer	1.86e-05	0.000216	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—lung cancer	1.86e-05	0.000216	CcSEcCtD
Fludarabine—Vomiting—Docetaxel—lung cancer	1.84e-05	0.000213	CcSEcCtD
Fludarabine—Dyspepsia—Methotrexate—lung cancer	1.84e-05	0.000213	CcSEcCtD
Fludarabine—Rash—Docetaxel—lung cancer	1.82e-05	0.000211	CcSEcCtD
Fludarabine—Dermatitis—Docetaxel—lung cancer	1.82e-05	0.000211	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—lung cancer	1.82e-05	0.000211	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—lung cancer	1.81e-05	0.00021	CcSEcCtD
Fludarabine—Headache—Docetaxel—lung cancer	1.81e-05	0.00021	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—lung cancer	1.81e-05	0.000209	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—lung cancer	1.81e-05	0.000209	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—lung cancer	1.8e-05	0.000209	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—lung cancer	1.8e-05	0.000208	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTP1—lung cancer	1.8e-05	0.000556	CbGpPWpGaD
Fludarabine—Infection—Doxorubicin—lung cancer	1.79e-05	0.000208	CcSEcCtD
Fludarabine—Pain—Methotrexate—lung cancer	1.78e-05	0.000207	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—lung cancer	1.77e-05	0.000205	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—lung cancer	1.77e-05	0.000205	CcSEcCtD
Fludarabine—RRM1—Metabolism—CAT—lung cancer	1.75e-05	0.000541	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Doxorubicin—lung cancer	1.75e-05	0.000202	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.73e-05	0.000536	CbGpPWpGaD
Fludarabine—Anorexia—Doxorubicin—lung cancer	1.72e-05	0.0002	CcSEcCtD
Fludarabine—Nausea—Docetaxel—lung cancer	1.72e-05	0.000199	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—lung cancer	1.72e-05	0.000199	CcSEcCtD
Fludarabine—RRM1—Metabolism—ABCB1—lung cancer	1.7e-05	0.000526	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.68e-05	0.000519	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP2E1—lung cancer	1.68e-05	0.000518	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMS—lung cancer	1.67e-05	0.000517	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—RB1—lung cancer	1.66e-05	0.000514	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NQO1—lung cancer	1.66e-05	0.000513	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM1—lung cancer	1.65e-05	0.000511	CbGpPWpGaD
Fludarabine—Body temperature increased—Methotrexate—lung cancer	1.65e-05	0.000191	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.65e-05	0.000191	CcSEcCtD
Fludarabine—Paraesthesia—Doxorubicin—lung cancer	1.62e-05	0.000188	CcSEcCtD
Fludarabine—Dyspnoea—Doxorubicin—lung cancer	1.61e-05	0.000187	CcSEcCtD
Fludarabine—Dyspepsia—Doxorubicin—lung cancer	1.59e-05	0.000184	CcSEcCtD
Fludarabine—Decreased appetite—Doxorubicin—lung cancer	1.57e-05	0.000182	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP1A1—lung cancer	1.57e-05	0.000484	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Doxorubicin—lung cancer	1.56e-05	0.000181	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—lung cancer	1.56e-05	0.00018	CcSEcCtD
Fludarabine—RRM1—Metabolism—ERCC2—lung cancer	1.55e-05	0.00048	CbGpPWpGaD
Fludarabine—Constipation—Doxorubicin—lung cancer	1.54e-05	0.000179	CcSEcCtD
Fludarabine—Pain—Doxorubicin—lung cancer	1.54e-05	0.000179	CcSEcCtD
Fludarabine—Hypersensitivity—Methotrexate—lung cancer	1.54e-05	0.000178	CcSEcCtD
Fludarabine—Asthenia—Methotrexate—lung cancer	1.5e-05	0.000173	CcSEcCtD
Fludarabine—DCK—Metabolism—STK11—lung cancer	1.49e-05	0.000462	CbGpPWpGaD
Fludarabine—Feeling abnormal—Doxorubicin—lung cancer	1.49e-05	0.000173	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—RB1—lung cancer	1.48e-05	0.000459	CbGpPWpGaD
Fludarabine—Pruritus—Methotrexate—lung cancer	1.48e-05	0.000171	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—lung cancer	1.46e-05	0.000451	CbGpPWpGaD
Fludarabine—Body temperature increased—Doxorubicin—lung cancer	1.43e-05	0.000165	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—lung cancer	1.43e-05	0.000165	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.42e-05	0.000438	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTP1—lung cancer	1.38e-05	0.000428	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—lung cancer	1.36e-05	0.000421	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CAT—lung cancer	1.35e-05	0.000416	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOA1—lung cancer	1.34e-05	0.000415	CbGpPWpGaD
Fludarabine—Hypersensitivity—Doxorubicin—lung cancer	1.33e-05	0.000154	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—lung cancer	1.33e-05	0.000154	CcSEcCtD
Fludarabine—Rash—Methotrexate—lung cancer	1.31e-05	0.000152	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—lung cancer	1.31e-05	0.000152	CcSEcCtD
Fludarabine—DCK—Metabolism—ABCB1—lung cancer	1.31e-05	0.000405	CbGpPWpGaD
Fludarabine—Headache—Methotrexate—lung cancer	1.31e-05	0.000151	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN2A—lung cancer	1.31e-05	0.000404	CbGpPWpGaD
Fludarabine—Asthenia—Doxorubicin—lung cancer	1.3e-05	0.00015	CcSEcCtD
Fludarabine—DCK—Metabolism—TYMS—lung cancer	1.29e-05	0.000398	CbGpPWpGaD
Fludarabine—Pruritus—Doxorubicin—lung cancer	1.28e-05	0.000148	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTM1—lung cancer	1.27e-05	0.000393	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MDM2—lung cancer	1.27e-05	0.000391	CbGpPWpGaD
Fludarabine—Nausea—Methotrexate—lung cancer	1.24e-05	0.000144	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—lung cancer	1.24e-05	0.000143	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—lung cancer	1.23e-05	0.000381	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CG—lung cancer	1.23e-05	0.000379	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1A1—lung cancer	1.2e-05	0.000373	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ERCC2—lung cancer	1.19e-05	0.000369	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—lung cancer	1.19e-05	0.000369	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—POMC—lung cancer	1.17e-05	0.000361	CbGpPWpGaD
Fludarabine—Vomiting—Doxorubicin—lung cancer	1.15e-05	0.000133	CcSEcCtD
Fludarabine—Rash—Doxorubicin—lung cancer	1.14e-05	0.000132	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—lung cancer	1.14e-05	0.000132	CcSEcCtD
Fludarabine—RRM1—Metabolism—CREBBP—lung cancer	1.14e-05	0.000352	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—EP300—lung cancer	1.14e-05	0.000351	CbGpPWpGaD
Fludarabine—Headache—Doxorubicin—lung cancer	1.13e-05	0.000131	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CCND1—lung cancer	1.1e-05	0.000341	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CD—lung cancer	1.08e-05	0.000333	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—lung cancer	1.07e-05	0.000124	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN1A—lung cancer	1.07e-05	0.00033	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—lung cancer	1.06e-05	0.000329	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOA1—lung cancer	1.03e-05	0.00032	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK3—lung cancer	1.02e-05	0.000315	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—EP300—lung cancer	1.02e-05	0.000314	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—lung cancer	9.89e-06	0.000306	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CG—lung cancer	9.44e-06	0.000292	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CB—lung cancer	9.4e-06	0.000291	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—lung cancer	9.31e-06	0.000288	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK3—lung cancer	9.09e-06	0.000281	CbGpPWpGaD
Fludarabine—DCK—Metabolism—POMC—lung cancer	8.98e-06	0.000278	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—lung cancer	8.85e-06	0.000274	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CREBBP—lung cancer	8.75e-06	0.000271	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CD—lung cancer	8.3e-06	0.000256	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALB—lung cancer	8.19e-06	0.000253	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—lung cancer	8.12e-06	0.000251	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—EP300—lung cancer	7.74e-06	0.000239	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—lung cancer	7.26e-06	0.000225	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CB—lung cancer	7.23e-06	0.000224	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—lung cancer	7.16e-06	0.000222	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTEN—lung cancer	6.25e-06	0.000193	CbGpPWpGaD
Fludarabine—DCK—Metabolism—EP300—lung cancer	5.96e-06	0.000184	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—lung cancer	5.73e-06	0.000177	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—lung cancer	4.68e-06	0.000145	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—lung cancer	4.41e-06	0.000136	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—lung cancer	3.6e-06	0.000111	CbGpPWpGaD
